Lacerda R - Search Results

1

Genetics of personalized medicine: cancer and rare diseases.

Alves ITS, Condinho M, Custódio S, Pereira BF, Fernandes R, Gonçalves V, da Costa PJ, Lacerda R, Marques AR, Martins-Dias P, Nogueira GR, Neves AR, Pinho P, Rodrigues R, Rolo E, Silva J, Travessa A, Leite RP, Sousa A, Romão L. Alves ITS, et al. Among authors: lacerda r. Cell Oncol (Dordr). 2018 Jun;41(3):335-341. doi: 10.1007/s13402-018-0379-3. Epub 2018 Apr 9. Cell Oncol (Dordr). 2018. PMID: 29633150

2

More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancer.

Lacerda R, Menezes J, Romão L. Lacerda R, et al. Cell Mol Life Sci. 2017 May;74(9):1659-1680. doi: 10.1007/s00018-016-2428-2. Epub 2016 Dec 2. Cell Mol Life Sci. 2017. PMID: 27913822 Review.

3

Cap-independent translation ensures mTOR expression and function upon protein synthesis inhibition.

Marques-Ramos A, Candeias MM, Menezes J, Lacerda R, Willcocks M, Teixeira A, Locker N, Romão L. Marques-Ramos A, et al. Among authors: lacerda r. RNA. 2017 Nov;23(11):1712-1728. doi: 10.1261/rna.063040.117. Epub 2017 Aug 18. RNA. 2017. PMID: 28821580 Free PMC article.

4

eIF3: a factor for human health and disease.

Gomes-Duarte A, Lacerda R, Menezes J, Romão L. Gomes-Duarte A, et al. Among authors: lacerda r. RNA Biol. 2018 Jan 2;15(1):26-34. doi: 10.1080/15476286.2017.1391437. Epub 2017 Nov 13. RNA Biol. 2018. PMID: 29099306 Free PMC article. Review.

5

Internal Ribosome Entry Site (IRES)-Mediated Translation and Its Potential for Novel mRNA-Based Therapy Development.

Marques R, Lacerda R, Romão L. Marques R, et al. Among authors: lacerda r. Biomedicines. 2022 Aug 2;10(8):1865. doi: 10.3390/biomedicines10081865. Biomedicines. 2022. PMID: 36009412 Free PMC article. Review.

6

Conserved Double Translation Initiation Site for Δ160p53 Protein Hints at Isoform's Key Role in Mammalian Physiology.

López-Iniesta MJ, Parkar SN, Ramalho AC, Lacerda R, Costa IF, Zhao J, Romão L, Candeias MM. López-Iniesta MJ, et al. Among authors: lacerda r. Int J Mol Sci. 2022 Dec 13;23(24):15844. doi: 10.3390/ijms232415844. Int J Mol Sci. 2022. PMID: 36555484 Free PMC article.

7

DIS3L2 knockdown impairs key oncogenic properties of colorectal cancer cells via the mTOR signaling pathway.

García-Moreno JF, Lacerda R, da Costa PJ, Pereira M, Gama-Carvalho M, Matos P, Romão L. García-Moreno JF, et al. Among authors: lacerda r. Cell Mol Life Sci. 2023 Jun 20;80(7):185. doi: 10.1007/s00018-023-04833-5. Cell Mol Life Sci. 2023. PMID: 37340282 Free PMC article.

8

Alternative Mechanisms of mRNA Translation Initiation in Cellular Stress Response and Cancer.

Lacerda R, Menezes J, Candeias MM. Lacerda R, et al. Adv Exp Med Biol. 2019;1157:117-132. doi: 10.1007/978-3-030-19966-1_6. Adv Exp Med Biol. 2019. PMID: 31342440

9

Digital resources in the monitoring of patients with cleft lip and palate: protocol for a scoping review.

Carvalho LIM, de Araújo EGO, de Souza BES, Martins HDD, Lacerda RHW, Bonan PRF. Carvalho LIM, et al. Among authors: lacerda rhw. BMJ Open. 2024 Apr 29;14(4):e079698. doi: 10.1136/bmjopen-2023-079698. BMJ Open. 2024. PMID: 38684274 Free PMC article. Review.

10

CLEFT RR- New app to Calculate Recurrence Risk in Cleft lip and Palate.

Lacerda RHW, Mendonça ACG, Laurentino RA, Furtado PGC, Filgueiras VM, Filgueiras FMB, Bezerra LCDS, Vieira AR. Lacerda RHW, et al. Cleft Palate Craniofac J. 2023 Aug 6:10556656231191346. doi: 10.1177/10556656231191346. Online ahead of print. Cleft Palate Craniofac J. 2023. PMID: 37545187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page